Abstract:In this research study, the authors successfully synthesized potent new anticancer agents derived from indazol-pyrimidine. All the prepared compounds were tested for in vitro cell line inhibitory activity against three different cancerous cell lines. Results demonstrated that five of the novel compounds-4f, 4i, 4a, 4g, and 4d-possessed significant cytotoxic inhibitory activity against the MCF-7 cell line, with IC50 values of 1.629, 1.841, 2.958, 4.680, and 4.798 μM, respectively, compared to the reference drug with an IC50 value of 8.029 μM, thus demonstrating promising suppression power. Compounds 4i, 4g, 4e, 4d, and 4a showed effective cytotoxic activity stronger than the standard against Caco2 cells. Moreover, compounds 4a and 4i exhibited potent antiproliferative activity against the A549 cell line that was stronger than the reference drug. The most active products, 4f and 4i, werr e further examined for their mechanism of action. It turns out that they were capable of activating caspase-3/7 and, therefore, inducing apoptosis. However, produced a higher safety profile than the reference drug, towards the normal cells (MCF10a). Furthermore, the dynamic nature, binding interaction, and protein-ligand stability were explored through a Molecular Dynamics (MD) simulation study. Various analysis parameters (RMSD, RMSF, RoG, and SASA) from the MD simulation trajectory have suggested the stability of the compounds during the 20 ns MD simulation study. In silico ADMET results revealed that the synthesized compounds had low toxicity, good solubility, and an absorption profile since they met Lipinski's rule of five and Veber's rule. The present research highlights the potential of derivatives with indazole scaffolds bearing pyrimidine as a lead compound for designing anticancer agents.

Synthesis and Biological Evaluation of N-(2,3-Dimethyl-2H-Indazol-6-yl)-2-Methylpyrimidinediamine Derivatives

Synthesis, Crystal Structure and Evaluation of Cancer Inhibitory Activity of 4-[Indol-3-yl-methylene]-1h-pyrazol-5(4h)-one Derivatives

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Synthesis And Antitumor Activity Of 5-Bromo-7-Azaindolin-2-One Derivatives Containing A 2,4-Dimethyl-1h-Pyrrole-3-Carboxamide Moiety

[Synthesis and Biological Evaluation of 3-Aromatic Shiff Base-5-fluoroindol-2-one Derivatives].

Synthesis and Biological Evaluation of 3-((1-Methyl-1H-pyrrol-2-yl)methylene)indolin-2-one Derivatives as Potent Anticancer Active Agents

Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents

Synthesis and antitumor activity of 5-[1-(3-(dimethylamino)propyl)-5-halogenated-2-oxoindolin-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxamides.

Synthesis and Antitumor Activity of 5-(5-Halogenated-2-oxo-1h-pyrrolo[2,3-b]pyridin-(3z)-ylidenemethyl)-2,4-dimethyl-1h-pyrrole-3-carboxamides

Design, Synthesis and Biological Activity of Pyrazolo[3,4-d]pyrimidine Derivatives Containing Indole Moiety

Synthesis and Antitumor Activities of Novel Indazole Derivatives

Design, Synthesis And Biological Evaluation Of Of Novel Anticancer Agent Tert-Butyl 1-Phenyl-3,4-Dihydro-1h-Pyrido[3,4-B]Indole-2(9h)-Carboxylate

Synthesis and Biological Evaluation of Novel Pazopanib Derivatives As Antitumor Agents

Synthesis of 1-Furfuryl-indolin-2-one Derivatives and Preliminary Evaluation of Their Antitumor Activities

Synthesis and Antitumor Activity of Indolemalylimide Derivatives

Design, synthesis and antitumor activities of oxazolo[5,4-d] pyrimidine derivatives

New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives

Synthesis and Anti-tumor Activities of Novel Hexahydro-1H-pyrido[2,3-b] Indole Compounds

Synthesis and antiproliferative activities of novel 2-substituted-4-aminothieno[3,2-d]pyrimidine derivatives

Design, Synthesis and Antitumor Activity Evaluation Research of Novel 2,4,6-Substituted Pyrimidine Derivatives